Dosage varies based on: Type of diabetes Blood glucose monitoring results Metabolic needs, or how the body uses food for energy Goals for glycemic control Xultophy (Insulin Degludec and ...

Both products combine a long acting insulin with a GLP-1 analogue ... Novo’s data from its phase 3b DUAL V trial, meanwhile, shows Xultophy treatment meant patients were up to 4.5 times ...

The growing incidence of type 2 diabetes is particularly expected to fuel the growth of the Xultophy 100 or 3.6 market. Type 2 diabetes, a chronic condition characterized by insulin resistance and ...